Oncology nurses play a key role guiding patients about AI breast cancer risk assessment tools, dynamic re-testing, and individualized screening plans.
|Articles|October 26, 2015
Laura Tang on Classifications of Neuroendocrine Tumors
Author(s)Laura Tang, MD, PhD
Laura Tang, MD, PhD, a pathologist at Memorial Sloan Kettering Cancer Center, discusses the classifications of advanced neuroendocrine tumors (NETs).
Advertisement
Laura Tang, MD, PhD, a pathologist at Memorial Sloan Kettering Cancer Center, discusses the classifications of advanced neuroendocrine tumors (NETs).
NETs are classified as well-differentiated or poorly-differentiated.
Patients with well-differentiated, high grade (G3) NETs generally do not experience symptoms and their tumors are often diagnosed incidentally.
Patients with poorly-differentiated tumors are typically very ill and present with dramatic symptoms such as abdominal pain, weight loss, and jaundice.
Advertisement
Related to this article
Dana-Farber nurse practitioners outline ADC patient selection, sequencing, ILD surveillance, and patient education from JADPRO Live 2026.
Dr. Andrew Pecora on leading the first IV oncolytic virus trial, building a top-50 cancer center, and using AI to fix the cost of cancer care.
In the phase 2 EVITA trial, vitamin C did not slow clonal growth but was linked to fewer serious adverse events and longer exploratory survival.
In observation of National PA Week, Moffitt PA Mark Honor discusses the expansion of APPs and key collaboration strategies for oncology nurses.
Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.
Oncology clinicians gathered to review relapsed CLL care options, CAR T-cell trial updates, and advanced practice provider roles.
At ASTRO 2026, Suresh Rana details how AI-driven contouring accelerates care timelines, requiring rigorous team monitoring and early nursing input.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
AI Breast Cancer Risk Models Guide Triage and Nurse-Led Patient Counseling
2
Sunvozertinib Now Available in US for Pretreated EGFR Exon 20+ NSCLC
3
What Oncology Nurses Need to Know About ADCs in Breast Cancer
4
Male Breast Cancer: Warning Signs, Biology, and Genetic Testing
5